Pharmexcil to conduct intl business meet on sidelines of IPC to expand business opportunities of Ind.

With a view to help the pharma exporters and manufacturers, especially the SME pharma companies from the South, to expand their business opportunities into overseas markets, the Pharmaceutical Export Promotion Council of India (Pharmexcil) will organise an International Business Meet from December 7 to 9 in Chennai on the sidelines of the 64th Indian Pharmaceutical Congress (IPC).

The meet will be conducted at the SRM University campus with the active cooperation of Indian Pharmaceutical Congress Association (IPCA), consisting of IPA, IPGA, IHPA, APTI and AIDCOC.

It is expected that the business congress will help increase India’s pharmaceutical exports in 2012-13.

“This is a great opportunity for the pharma manufacturers of Tamil Nadu and those attending the Indian Pharmaceutical Congress (IPC) to meet and interact with exporters and importers from various parts of the country and from abroad on one platform.

The main objective of the business meet is to provide opportunity for the Indian pharma exporters, particularly from SME sector, to meet about 40 prominent buyers, drug regulatory officials and government procurement agencies of different countries across the globe,” said Dr P V Appaji, director general of the Pharmexcil.

About 40 delegates from major countries in the Latin American Countries (LAC), Commonwealth Independent States (CIS), ASEAN, Africa, Europe and Oceania will be invited to the meet to interact with the exporters and manufacturers of Indian pharmaceutical sector.

But more emphasize will be given on meeting with the buyers and the programmes are conveniently divided into four sessions, he added.

When contacted, the organising secretary of IPC this year J Jayaseelan said the Pharmexcil’s business meet will definitely help the exporters and the small scale pharma manufacturers of Tamil Nadu.

All the manufacturers can meet international buyers and sellers at one place and think of how to expand their business into the global markets.

The meet will also highlight India’s strength to supply quality generic medicines at affordable prices, he pointed out.

The organisers of the business meet feel that the meet will help exchange updated information on drug regulatory procedures in India and other countries. Further, commercial and technical cooperation among countries  can be increased.

Prominent buyers / importers of pharmaceutical products from different countries, FDA officials and pharma consultants from India will attend the Pharmexcil event.

The business sessions in the Congress will cover discussions on Active Pharmaceutical Ingredients (APIs), Formulations, Biotech & Biological Products, Ayush products, veterinary drugs, R&D, clinical trials, contact manufacturing and pharma related services.


Source : pharmabiz.com